Advances in the Evaluation and Management of Esophageal Disease of Systemic Sclerosis

Symptoms of heartburn and dysphagia as well as objective findings of abnormal esophageal acid exposure and csophagcal dysmotility are common in patients with systemic sclerosis (SSc). Treatments for SSc esophageal disease are generally limited to gastrocsophagcal reflux disease (GERD) treatment with proton pump inhibitors. Progresses made in esophageal diagnostic testing offer the potential for improved clinical characterization of esophageal disease in SSc that may help direct management decisions. In addition to reviewing GERD management in patients with SSc, present and potential uses of endoscopy, reflux monitoring, manometry, impedance planimetry, and endoscopic ultrasound are discussed.